LONSPYRA
Live / Allowed — Fourth extension granted (statement of use) (as of 20 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Oct 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98217379
- Mark type
- Word mark
- Filed
- 10 Oct 2023
- Published for opposition
- 02 Jul 2024
- Attorney of record
- Jeannine Rittenhouse
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of rare neurological disorders, not including dermatological disorders
Owner
- MANDOS LLC, West Hollywood, CA, US
- MANDOS LLC, West Hollywood, CA, US
Prosecution history
- 21 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2026 — SOU EXTENSION 4 GRANTED
- 20 Aug 2026 — SOU EXTENSION 4 FILED
- 20 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2026 — SOU EXTENSION 3 GRANTED
- 25 Feb 2026 — SOU EXTENSION 3 FILED
- 25 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Aug 2025 — SOU EXTENSION 2 GRANTED
- 25 Aug 2025 — SOU EXTENSION 2 FILED
- 25 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2025 — SOU EXTENSION 1 GRANTED
- 27 Feb 2025 — SOU EXTENSION 1 FILED